Publisher Correction: PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation

被引:0
|
作者
Chao Hu
Mengxia Yu
Yanling Ren
Kongfei Li
Dominic M. Maggio
Chen Mei
Li Ye
Juying Wei
Jie Jin
Zhengping Zhuang
Hongyan Tong
机构
[1] College of Medicine,Department of Hematology, The First Affiliated Hospital
[2] Zhejiang University,Department of Hematology
[3] Hangzhou First People’s Hospital,Myelodysplastic Syndromes Diagnosis and Therapy Center, The First Affiliated Hospital
[4] College of Medicine,Department of Hematology
[5] Zhejiang University,Surgical Neurology Branch
[6] Yin Zhou People’s Hospital,undefined
[7] National Institute of Neurological Disorders and Stroke,undefined
[8] National Institutes of Health,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
A correction to this article has been published and is linked from the HTML version of this paper. The error has been fixed in the paper.
引用
收藏
相关论文
共 3 条
  • [1] PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
    Chao Hu
    Mengxia Yu
    Yanling Ren
    Kongfei Li
    Dominic M. Maggio
    Chen Mei
    Li Ye
    Juying Wei
    Jie Jin
    Zhengping Zhuang
    Hongyan Tong
    Scientific Reports, 7
  • [2] PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation
    Hu, Chao
    Yu, Mengxia
    Ren, Yanling
    Li, Kongfei
    Maggio, Dominic M.
    Mei, Chen
    Ye, Li
    Wei, Juying
    Jin, Jie
    Zhuang, Zhengping
    Tong, Hongyan
    SCIENTIFIC REPORTS, 2017, 7
  • [3] PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation (vol 7, 2894, 2017)
    Hu, Chao
    Yu, Mengxia
    Ren, Yanling
    Li, Kongfei
    Maggio, Dominic M.
    Mei, Chen
    Ye, Li
    Wei, Juying
    Jin, Jie
    Zhuang, Zhengping
    Tong, Hongyan
    SCIENTIFIC REPORTS, 2017, 7